CAR-T Therapy Revolutionizing Cancer Treatment
The Human Genome Project’s completion in 2003 paved the way for personalized medicines tailored to individual patients.
One groundbreaking example is CAR-T therapy, an innovative immunotherapy that reprograms a patient’s own T-cells to target and destroy cancer cells.
In this process, researchers extract T-cells, modify them in a lab to produce chimeric antigen receptors (CARs) and then reintroduce these CARs into the patient to actively target and eradicate cancer. Researchers are currently developing nearly 800 CAR-T therapies, with a focus on enhancing efficacy, improving safety and streamlining manufacturing to further transform cancer care.
Our Work in Action
To maintain America’s global leadership, we need to support the next generation of innovation in medicine.
